CNBX Pharmaceuticals Inc.
03/17/2026 | Press release | Distributed by Public on 03/17/2026 06:30
Material Agreement (Form 8-K)
| Item 1.01. | Entry into a Material Definitive Agreement. |
On March 10th, 2026, the Company executed a non-convertible Promissory Note with 3i L.P., a Delaware Limited Partnership for the amount of $45,000. Said Note is due on July 1st, 2026, and bears simple interest at 5% per annum. The Company shall use the proceeds for immediate working capital purposes and expenditures.
CNBX Pharmaceuticals Inc. published this content on March 17, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 17, 2026 at 12:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]